After a year and a half at NSF

So, right now this blog is private because I’m very much in the public eye. But one day, when I return to academia, it’ll go public again. So I’ve decided to start writing again today.

Yes, running BIO at NSF is the most challenging job I’ve ever had in my life. I find myself working at, our beyond the level of intensity of my years in grad school in Ann Arbor. The high points are incredible. The low points are devastating. I certainly didn’t expect this type of life for my sixties.

Writing is like exercising. I’m out of practice. So it’ll be slow. But I’m ready to go ahead again.

Back from Prince Edward Island…

Where I was at a biotech conference and watched Mason’s own Professor Nadine Kabbani give a bang up excellent talk on her latest work with the alpha-7 nicotinic receptor (which happens to be G-protein linked).

I also got a good view of the progress (or lack of it) in the area of neurodegenerative diseases (such as Alzheimer’s). It’s frustrating because so much money has been invested and there has been so very little produced for the pipeline (and the patients).

Tomorrow we dive back into building Krasnow’s third decade of success….